Evaluation of race as a prognostic factor in multiple myeloma: An ancillary of Southwest Oncology Group study 8229

Journal of Clinical Oncology

Volumn 14, Issue 3, 1996, Pages 974-977

  Modiano, M R ^a   Villar Werstler, P ^a   Crowley, J ^a   Salmon, S E ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROGNOSIS; RACE; TREATMENT OUTCOME;

EID: 0029926247     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.3.974     Document Type: Article

References (30)

1. Closing the Gap: Cancer and Minorities. Silver Springs, MD, Office of Minority Health Resource Center, Department of Health and Human Services Publication, 1985
2. American Cancer Society: Cancer Facts and Figures. Publication 92-425M-No. 5008.92-LE. Atlanta, GA, American Cancer Society, 1992
3. Gloeckler Ries LA, Hankey BF, Edwards BK (eds): Cancer Statistics Review 1973-87. Bethesda, MD, National Cancer Institute Division of Cancer Prevention and Control Surveillance Program, US Department of Health and Human Services, Public Health Services, National Institutes of Health, NIH publication no. 90-2789, 1990
4. Steinhorn SC, Myers MH, Hankey BF, et al: Factors associated with survival differences between black women and caucasian women with cancer of the uterine corpus. Am J Epidemiol 124:85-92, 1986
5. Bang KM, White JE, Gause B, et al: Evaluation of recent trends in cancer mortality and incidence among blacks. Cancer 61:1255-1261, 1988
6. Axtell LM, Myers MH: Contrasts in survival of black and white cancer patients, 1960-73. J Natl Cancer Inst 60:1209-1215, 1978
7. McWhorter WP, Schatzkin AG, Horm JW, et al: Contribution of socioeconomic status to black/white differences in cancer incidence. Cancer 63:982-987, 1989
8. Hankey BF, Myers MH: Black/white differences in bladder cancer patient survival. J Chronic Dis 40:65-78, 1987
9. Johnson JM, Grufferman S, Bourguet CC, et al: Socioeconomic status and risk of multiple myeloma. J Epidemiol Commun Health 39:175-178, 1985
10. Cancer Among Blacks and Other Minorities: Statistical Profiles. Bethesda, MD, National Cancer Institute publication no. (NIH) 86-2785, March 1986
11. Reed E, Freireich EJ: Cancer treatment and support programs for minorities. Cancer Bull 40:92-93, 1988
12. Freeman H: Cancer in the socioeconomically disadvantaged. CA 39:266-288, 1989
13. Freeman H: Race, proverty and cancer. J Natl Cancer Inst 83:526-527, 1991
14. Baquet CR, Horm JW, Gibbs T, et al: Socioeconomic factors and cancer incidence among blacks and whites. J Natl Cancer Inst 83:551-557, 1991
15. Loehrer PJ, Greger HA, Weinberger M, et al: Knowledge and beliefs about cancer in a socioeconomically disadvantaged population. Cancer 68:1665-1671, 1991
16. Modiano MR, Moon TE: A community based approach to increasing preventive health care in Mexican-American women in Southern Arizona. Proceedings from The North American Conference on Cancer in Hispanics, Tucson, AZ, September 12-14, 1991, p 61 (abstr 24)
17. Villar Werstler P, Loescher LJ, Modiano MR, et al: Recruitment of minorities to clinical trials: Physicians as a referral source. Proceedings of American Society of Preventive Oncology, Seattle, WA, April 9-12, 1991 (abstr 53)
18. Modiano M, Villar Werstler P, Lash S, et al: Increasing enrollment of minorities into clinical trials through community involvement. Proc Am Soc Clin Oncol 11:147, 1992 (abstr 409)
19. Salmon SE, Tesh D, Crowley J, et al: Chemotherapy is supenor to sequential hemibody irradiation for remission consolidation in multiple myeloma: A Southwest Oncology Group study. J Clin Oncol 8:1575-1584, 1990
20. Chronic Leukemia-Myeloma Task Force, National Cancer Institute: Proposed guidelines for protocol studies II. Plasma cell myeloma. Cancer Chemother Rep 4:145-158, 1973
21. Goldie JH, Coldman AJ, Gudaskas GA: Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treat Rep 66:439-449, 1982
22. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
23. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
24. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-202, 1972
25. Weaver P, Harrison B, Eskander G, et al: Colon cancer in blacks: A disease with worsening prognosis. J Natl Med Assoc 83:133-136, 1991
26. Austin JP, Aziz H, Potters L, et al: Diminished survival of young blacks with adenocarcinoma of the prostate. Am J Clin Oncol 13:465-469, 1990
27. Natarajan N, Murphy GP, Mettlin C: Prostate cancer in blacks: An update from the American College of Surgeon's Patterns of Care Studies. J Surg Oncol 40:232-236, 1989
28. Lenhard RE, Enterline JP, Crowley J, et al: The effects of distance from primary treatment centers on survival among patients with multiple myeloma. J Clin Oncol 5:1640-1645, 1987
29. Savage D, Lindenbaum J, Van Ryzin J, et al: Race, poverty, and survival in multiple myeloma. Cancer 54:3085-3094, 1984
30. Chu KC, Kramer BS, Smart CR: Analysis of the role of cancer prevention and control measures in reducing cancer mortality. J Natl Cancer Inst 83:1636-1643, 1991